The first disease-modifying Alzheimer’s disease treatments are on the horizon, but health systems in the United States and Europe would have to take a number of steps to ensure they are ready to provide those treatments to the millions of people who need them, according to two USC reports presented this week at the Alzheimer’s Association International Conference.
Soeren Mattke, a USC research professor of economics at the Center for Economic and Social Research (CESR) at the USC Dornsife…
